1-14 of 14
Michael Kramer, M.Sc.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Azacitidine for Pre-Emptive Treatment of Measurable-Residual Disease in MDS/AML Patients at High Risk of Hematological Relapse: Results of the Second Cohort of the RELAZA2 Trial

Uwe Platzbecker, MD, Jan Moritz Middeke, MD, Katja Sockel, MD, Regina Herbst, MD, Lars R. Fransecky, MD, Dominik Wolf, MD, Schumacher Martin, MD, Alwin Krämer, MD, Richard Noppeney, MD, Juergen Novotny, MD, Gesine Bug, Katharina Götze, Karsten Spiekermann, MD, Matthias Stelljes, MD, Christoph Groth, MD, Marion Subklewe, MD, Antje Schubert, Anke Mütherig, MD, Tilmann Bochtler, MD, Marika Mende, MD, Anne Sophie Kubasch, MD, Mathias Hänel, MD, Ulrich Dührsen, Prof, MD PhD, Johannes Schetelig, MD MSc, Christoph Röllig, MD MSC, Claudia D Baldus, Gerhard Ehninger, MD, Carsten Müller-Tidow, MD, Hubert Serve, MD, Michael Kramer, M.Sc., Martin Bornhäuser, MD, Christian Thiede, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 644.
https://doi.org/10.1182/blood-2019-129926
Published: 2019
Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 13.
https://doi.org/10.1182/blood-2019-123717
Published: 2019
Journal Articles

Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3 -ITD: Results from an International Collaboration

Sabine Kayser, MD, Michelle A Elliott, MD, Marlise Luskin, MDMS, Andrew M. Brunner, MD, Michael Kramer, M.Sc., Zdenek Racil, MD, Zuzana Sustkova, MD, Petr Cetkovsky, MD MBA, PhD, Jan Novak, MD PhD, Friedrich Stoelzel, MD, Christian Thiede, MD, Carsten Müller-Tidow, MD, Uwe Platzbecker, Christoph Röllig, MD MSC, Richard F. Schlenk, MD, Mark J. Levis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2693.
https://doi.org/10.1182/blood-2019-125317
Published: 2019
Journal Articles

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

Jan Moritz Middeke, MD, Christoph Rollig, MD MSC, Michael Kramer, M.Sc., Alwin Kramer, MD, Tilman Bochtler, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Edgar Jost, MD, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, Kerstin Schäfer-Eckart, MD, Christoph Schliemann, MD, Stefan W Krause, MD, Regina Herbst, MD, Mathias Hänel, MD, Norbert Frickhofen, MD, Richard Noppeney, MD, Ulrich Kaiser, MD, Claudia D. Baldus, MD, Martin Kaufmann, MD, Zdenek Racil, MD, Sebastian Stasik, PhD, Katja Sockel, MD, Malte von Bonin, MD, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E. Berdel, MD, Jiri Mayer, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Johannes Schetelig, MD MSc, Christian Thiede, MD, Friedrich Stoelzel
Journal: Blood
Blood (2018) 132 (Supplement 1): 1461.
https://doi.org/10.1182/blood-2018-99-118128
Published: 2018
Journal Articles

PPM1D Mutations Are Rare in De Novo and Therapy-Related Acute Myeloid Leukemia

Mutlu Kartal-Kaess, MD, Tilmann Bochtler, Bianca Kraft, PhD, Michael Kirsch, Bettina Maier, PhD, Friedrich Stoelzel, Brigitte Mohr, Michael Kramer, M.Sc., Christoph Rollig, MD MSC, Christian Thiede, MD, Martin Bornhäuser, Gerhard Ehninger, MD, Carsten Müller-Tidow, Alwin Krämer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1472.
https://doi.org/10.1182/blood-2018-99-118566
Published: 2018
Journal Articles

EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia

Sebastian Stasik, PhD, Jan Moritz Middeke, MD, Michael Kramer, M.Sc., Christoph Rollig, MD MSC, Alwin Krämer, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Martina Crysandt, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, Kerstin Schäfer-Eckart, MD, Christoph Schliemann, MD, Stefan W Krause, MD, Regina Herbst, MD, Mathias Hänel, MD, Norbert Frickhofen, MD, Richard Noppeney, MD, Ulrich Kaiser, MD, Claudia D. Baldus, MD, Martin Kaufmann, MD, Zdenek Racil, MD, Uwe Platzbecker, Wolfgang E. Berdel, MD, Jiri Mayer, MD, Hubert Serve, MD, Carsten Müller-Tidow, Gerhard Ehninger, MD, Martin Bornhäuser, Johannes Schetelig, MD, Christian Thiede, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1528.
https://doi.org/10.1182/blood-2018-99-114421
Published: 2018
Journal Articles

Impact of Donor Chimerism-Guided Immunomodulation after Allogeneic Stem Cell Transplant on the Outcome of Patients with AML and MDS

Juliane Steinmann, Sarah Lindner, MD, Zuzana Jedlickova, MD, Salem Ajib, MD, Saskia C. Gueller, MD, Tobias Berg, MD, Julia Riemann, MD, Fabian Lang, MD, Rosa Toenges, MD, Hans Martin, MD, Michael Kramer, M.Sc., Johannes Schetelig, MD MSc, Hubert Serve, MD, Christian Thiede, MD, Gesine Bug
Journal: Blood
Blood (2018) 132 (Supplement 1): 2133.
https://doi.org/10.1182/blood-2018-99-116088
Published: 2018
Journal Articles

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Christoph Rollig, MD MSC, Hubert Serve, Andreas Hüttmann, MD, Richard Noppeney, MD, Carsten Müller-Tidow, Utz Krug, Claudia D. Baldus, MD, Christian H. Brandts, MD, Volker Kunzmann, MD PhD, Hermann Einsele, Alwin Krämer, MD, Kerstin Schäfer-Eckart, MD, Andreas Neubauer, MD, Andreas Burchert, MD, Aristoteles Giagounidis, MD, Stefan W. Krause, Andreas Mackensen, MD, Walter E. Aulitzky, MD, Regina Herbst, MD, Mathias Hänel, MD, Alexander Kiani, Norbert Frickhofen, MD, Johannes Kullmer, Ulrich Kaiser, MD, Hartmut Link, MD PhD, Thomas Geer, MD, Albrecht Reichle, MD, Christian Junghanss, MD, Roland Repp, MD, Frank Heits, MD, Heinz Albert Durk, Thomas Illmer, Martin Bornhäuser, MD, Markus Schaich, MD, Stefani Barbara Parmentier, MD, Martin Goerner, MD, Christian Thiede, MD, Malte von Bonin, MD, Johannes Schetelig, MD, Michael Kramer, M.Sc., Wolfgang E. Berdel, Gerhard Ehninger
Journal: Blood
Blood (2017) 130 (Supplement 1): 721.
https://doi.org/10.1182/blood.V130.Suppl_1.721.721
Published: 2017
Journal Articles

Validation of the ELN 2017 Classification for AML with Intermediate Risk Cytogenetics with or without NPM1 -Mutations and High or Low Ratio FLT3-ITD s

Johannes Schetelig, MD, Christoph Rollig, MD MSC, Sabine Kayser, MD, Friedrich Stoelzel, MD, Kerstin Schaefer-Eckart, MD, Mathias Haenel, Wolf Roesler, Hermann Einsele, Martin Kaufmann, MD, Hubert Serve, Gesine Bug, MD, Alwin Kraemer, MD, Wolfgang E. Berdel, Matthias Stelljes, MD, Jiri Mayer, Prof, MD SCs, Albrecht Reichle, MD, Claudia D. Baldus, MD, Norbert Schmitz, Jan Moritz Middeke, MD, Michael Kramer, M.Sc., Gerhard Ehninger, Martin Bornhäuser, MD, Christian Thiede, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2694.
https://doi.org/10.1182/blood.V130.Suppl_1.2694.2694
Published: 2017
Journal Articles

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Uwe Platzbecker, MD, Eva Lengfelder, MD, Kerstin Schäfer-Eckart, MD, Katharina S Götze, MD, Michael Heuser, MD, Felicitas Thol, MD, Helmut R. Salih, MD, Mathias Hänel, MD, Karsten Spiekermann, Sonja Martin, MD, Sigrid Machherndl-Spandl, MD, Volker Kunzmann, MD, Andreas Jakob, MD, Hans-Joachim Tischler, MD, Dirk Niemann, MD, Joerg Mezger, MD, Tilmann Bochtler, MD, Stefan Krause, MD, Maike de Wit, MD, Claudia D. Baldus, MD, Richard Greil, MD, Jochen Greiner, Mark Ringhoffer, MD, Markus Radsak, MD, Mohammed Amen Wattad, MD, Wolff Schmiegel, MD, Elisabeth Koller, MD, Frank Heits, MD, Albrecht Reichle, MD, Stephan Kremers, MD, Andreas Hochhaus, MD, Nadezda Basara, MD, Dominik Wolf, MD, Martin Goerner, MD, Markus Schaich, MD, Harald Biersack, MD, Heinz Kirchen, MD, Thomas Kubin, MD, Gregor Aschauer, MD, Tanja Hesse, MD, Hartmut Link, MD PhD, Heinz Duerk, MDPhD, Dorit Kuerschner, MD, Walter Fiedler, MD, Bernd Hertenstein, MD, Martin Puttrich, Michael Kramer, M.Sc., Michaela Sauer, Wolfgang Hiddemann, Ulrich Duehrsen, MD, Hubert Serve, Christian Thiede, MD, Arnold Ganser, MD, Tim H. Brummendorf, MD, Konstanze Dohner, MD, Martin Bornhäuser, MD, Richard F. Schlenk, MD, Christoph Rollig, MD MSC, Hartmut Döhner, MD, Gerhard Ehninger, Peter Paschka, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2618.
https://doi.org/10.1182/blood.V130.Suppl_1.2618.2618
Published: 2017
Journal Articles

Real World Data on Decitabine Treatment in 296 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations

Christoph Rollig, MD MSC, Jan Moritz Middeke, MD, Sebastian Stasik, Armin Zebisch, MD, Heinz Sill, MD, Michael Kramer, M.Sc., Sebastian Scholl, MD, Andreas Hochhaus, MD, Edgar Jost, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, Hubert Serve, Heidi Altmann, Volker Kunzmann, MD PhD, Hermann Einsele, Stefani Barbara Parmentier, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, MD, Frank Heits, MD, Wolfgang E. Berdel, Katja Sockel, MD, Friedrich Stoelzel, MD, Uwe Platzbecker, MD, Gerhard Ehninger, Martin Bornhäuser, MD, Johannes Schetelig, MD, Christian Thiede, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3896.
https://doi.org/10.1182/blood.V130.Suppl_1.3896.3896
Published: 2017
Journal Articles

Induction Therapy for AML with 90 Mg/m² Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m² Daunorubicin

Stefan D Dendorfer, Michael Kramer, M.Sc., Katharina Schmidt-Brücken, Friedrich Stoelzel, MD, Regina Herbst, MD, Richard Noppeney, MD, Zdenek Racil, MD, Jiri Mayer, Prof, MD SCs, Björn Steffen, Tilman Bochtler, MD, Alwin Krämer, MD, Carsten Müller-Tidow, Kerstin Schäfer-Eckart, MD, Andreas Burchert, MD, Andreas Neubauer, MD, Claudia D. Baldus, MD, Christoph Schliemann, Martin Kaufmann, MD, Edgar Jost, Ralph Naumann, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Hubert Serve, Wolfgang E. Berdel, Gerhard Ehninger, Martin Bornhäuser, MD, Christoph Rollig, MD MSC
Journal: Blood
Blood (2017) 130 (Supplement 1): 3901.
https://doi.org/10.1182/blood.V130.Suppl_1.3901.3901
Published: 2017
Journal Articles

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Frederick Fasslrinner, MD, Johannes Schetelig, MD, Andreas Burchert, MD, Michael Kramer, M.Sc., Rudolf Trenschel, MD, Ute Hegenbart, Michael Stadler, MD PhD, Kerstin Schäfer-Eckart, MD, Michael Bätzel, Hans Eich, MD, Rita Engenhart-Cabillic, MD, Mechthild Krause, MD, Peter Dreger, MD, Andreas Neubauer, MD, Gerhard Ehninger, Dietrich W Beelen, MD PhD, Wolfgang E. Berdel, Timo Siepmann, MD, Matthias Stelljes, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4586.
https://doi.org/10.1182/blood.V130.Suppl_1.4586.4586
Published: 2017
Journal Articles

Minimal-Residual Disease Guided Treatment with Azacitidine in MDS/AML Patients at Imminent Risk of Relapse: Results of the Prospective RELAZA2 Trial

Uwe Platzbecker, MD, Jan Moritz Middeke, MD, Katja Sockel, MD, Anke Mütherig, MD, Regina Herbst, MD, Mathias Hänel, MD, Dominik Wolf, MD, Claudia D. Baldus, MD, Lars Fransecky, MD, Richard Noppeney, MD, Gesine Bug, MD, Katharina S Götze, MD, Alwin Krämer, MD, Tilman Bochtler, MD, Karsten Spiekermann, Marion Subklewe, MD, Matthias Stelljes, MD, Christoph Groth, MD, Antje Schubert, Hubert Serve, Ulrich Duehrsen, MD, Johannes Schetelig, MD, Christoph Rollig, MD MSC, Michael Kramer, M.Sc., Gerhard Ehninger, Martin Bornhäuser, MD, Christian Thiede, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 565.
https://doi.org/10.1182/blood.V130.Suppl_1.565.565
Published: 2017